Development of primary central nervous system lymphoma in a systemic lupus erythematosus patient after treatment with mycophenolate mofetil and review of the literature

Balci, M.A.; Pamuk, G.E.; Unlu, E.; USTA, UFUK; Pamuk, O.N.

doi:10.1177/0961203317691370

Development of primary central nervous system lymphoma in a systemic lupus erythematosus patient after treatment with mycophenolate mofetil and review of the literature

Balci M., Pamuk G., Unlu E., USTA U., Pamuk O.

Lupus, cilt.26, sa.11, ss.1224-1227, 2017 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 26 Sayı: 11
Basım Tarihi: 2017
Doi Numarası: 10.1177/0961203317691370
Dergi Adı: Lupus
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.1224-1227
Anahtar Kelimeler: haematological changes, nephritis, Systemic lupus erythematosus
Trakya Üniversitesi Adresli: Evet

Özet

Primary central nervous system lymphoma (PCNSL) is a rare form of extranodal non-Hodgkin lymphoma and four cases of PCNSL have previously been described in association with mycophenolate mofetil. We report the fifth case of PCNSL in a patient with lupus nephropathy while on mycophenolate mofetil treatment.